M. Cruz-Ramos

发表

Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer.

C. Villarreal-Garza, A. Ferrigno, F. Mesa-Chavez, 2021, Clinical breast cancer.

CAR-T cell and Personalized Medicine.

J. García-Foncillas, M. Cruz-Ramos, 2019, Advances in experimental medicine and biology.

Acellular fraction from malignant effusions has cytotoxicity in breast cancer cells.

M. Cruz-Ramos, J. Vargas-Villarreal, F. González-Salazar, 2021, Molecular and clinical oncology.

Patients’ satisfaction with a supportive care program for young breast cancer patients in Mexico: Joven & Fuerte supports patients’ needs and eases their illness process

C. Villarreal-Garza, F. Mesa-Chavez, A. Platas, 2020, Supportive Care in Cancer.

Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas

A. Cebrián, J. García-Foncillas, M. Cruz-Ramos, 2020, Neuroendocrinology.

Prospective Study of Fertility Preservation in Young Women With Breast Cancer in Mexico.

C. Villarreal-Garza, F. Mesa-Chavez, A. Fonseca, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study

A. Cebrián, J. García-Foncillas, M. Cruz-Ramos, 2019, Neuroendocrinology.

An overview of resistance to chemotherapy in osteosarcoma and future perspectives

M. Cruz-Ramos, D. García-Ortega, Sara Aileen Cabrera-Nieto, 2022, Cancer drug resistance.

Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study

A. Cebrián, J. García-Foncillas, C. Caramés, 2016, BMC Cancer.

Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.

A. Cebrián, J. García-Foncillas, M. Cruz-Ramos, 2019, Journal of geriatric oncology.

NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19

M. Cruz-Ramos, L. Gómez-Quiroz, B. Palacios-González, 2020, Frontiers in Immunology.

ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men

M. M. Mata-Miranda, M. Cruz-Ramos, J. Granados, 2022, Frontiers in Immunology.

Nutritional status and chemotherapy-associated toxicity in patients with cervical cancer

M. Cruz-Ramos, E. Gómez-García, Mario A Rosas-Sánchez, 2017, Gaceta Mexicana de Oncolog�a.

Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer

A. Cebrián, J. García-Foncillas, C. Caramés, 2016, Journal of cellular and molecular medicine.

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico

C. Villarreal-Garza, A. Ferrigno, A. Fonseca, 2021, Breast.

Afatinib is active in osteosarcoma in osteosarcoma cell lines

M. Cruz-Ramos, F. Solca, J. Fernández-Torres, 2020, Journal of Cancer Research and Clinical Oncology.

The antioxidant activity of soursop decreases the expression of a member of the NADPH oxidase family.

M. Cruz-Ramos, C. Landa-Solís, A. López-Reyes, 2014, Food & function.

Communication Challenges Among Oncologists in Mexico

C. Villarreal-Garza, F. Mesa-Chavez, A. Platas, 2020, Journal of Cancer Education.

Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis

M. Cruz-Ramos, G. Martínez-Nava, L. Gómez-Flores-Ramos, 2024, Diagnostics.

Phase angle as a potential tool to evaluate chronic inflammatory state and predict quality of life deterioration in women with breast cancer and obesity: A narrative review

M. Cruz-Ramos, Sara Aileen Cabrera-Nieto, D. Pérez-Camargo, 2024, Nutrition.